Respiro Diagnostics
Develops breath-based diagnostic platform for lung cancer and respiratory diseases
£1MPre-Seed
Role not disclosedLoading investors…
Activity from announced rounds
Develops breath-based diagnostic platform for lung cancer and respiratory diseases
Provides identity verification, compliance and payment infrastructure for regulated UK businesses